Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With STEMI (DR-STEMI)

May 25, 2024 updated by: Grigorios Tsigkas, University Hospital of Patras

Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With ST-elevation Myocardial Infraction (STEMI): The DR-STEMI Trial

Recently, a novel distal transradial, through anatomical snuffbox, approach has been proposed for undertaking percutaneous coronary angiography and interventions. The existing literature has evaluated distal transradial access (dTRA) as a feasible and safe approach, with faster hemostasis, lower rates of periprocedural complications and reduced incidence of radial artery occlusion (RAO). Aim of the present study is to compare dTRA versus conventional TRA access in patients with STEMI undergoing coronary angiography and interventions regarding peri- and post-procedural characteristics.

Study Overview

Detailed Description

Gaining vascular access is the first, mandatory step for undertaking percutaneous coronary angiography and interventions. The recent guidelines, published by European Society of Cardiology (ESC), American College of Cardiology (ACC), American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI), propose TRA as the gold standard for acute coronary syndromes (ACS), chronic coronary syndrome (CCS) percutaneous coronary interventions (PCI). Recently, a novel distal transradial, through anatomical snuffbox, approach has been proposed. The existing literature has evaluated distal transradial access (dTRA) as a feasible and safe approach, with faster hemostasis, lower rates of periprocedural complications and reduced incidence of radial artery occlusion (RAO). Mutual point of all the previous RCTs is that excluded patients suffering from ST-elevation Myocardial Infraction (STEMI). Aim of the present study is to compare dTRA versus conventional TRA access in patients with STEMI undergoing coronary angiography and interventions regarding peri- and post-procedural characteristics.

Study Type

Interventional

Enrollment (Estimated)

554

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Charleroi, Belgium
        • Recruiting
        • Department of Cardiology, Centre Hospitalier Universitaire de Charleroi
        • Contact:
      • Patras, Greece, 26500
        • Recruiting
        • University Hospital of Patras
        • Contact:
      • Geneva, Switzerland
        • Recruiting
        • Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age > 18 years old
  • Indication: ST-Elevation Myocardial Infraction

Exclusion Criteria:

  • Non-palpable radial artery
  • Previous CABG
  • Anatomical restrictions for forearm approach
  • Hemodynamic instability
  • Previous radial artery catheterization from the same arm during the last 30-days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Distal transradial artery access
Vascular access after cannulation of distal transradial artery through anatomical snuffbox for coronary angiography and interventions
Coronary angiography +/- percutaneous coronary intervention
Active Comparator: Conventional transradial artery access
Vascular access after puncturing on the conventional transradial artery for performing coronary angiography and interventions
Coronary angiography +/- percutaneous coronary intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
needle-to-wire time
Time Frame: Immediately post-procedurally
needle-to-wire time
Immediately post-procedurally

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radial artery occlusion using Doppler examination prior to hospital discharge
Time Frame: The evaluation will be performed during hospitalization for STEMI and prior discharge, typically the 4th day after PCI
Radial artery patency evaluation with Doppler ultrasound prior to hospital discharge for detecting possible occlusion after cannulation
The evaluation will be performed during hospitalization for STEMI and prior discharge, typically the 4th day after PCI
Access site crossover rate
Time Frame: Immediately post-procedurally
Crossover rate from distal transradial artery access to other access point
Immediately post-procedurally
Sheath insertion time
Time Frame: Immediately post-procedurally
Duration required from the beginning of puncture until sheath insertion
Immediately post-procedurally
Total procedure time
Time Frame: Immediately post-procedurally
Total duration of coronary angiography and angioplasty
Immediately post-procedurally
The time interval between the initiation of radial artery puncture and the completion of coronary angiography, until the beginning of the possible PCI
Time Frame: Immediately post-procedurally
The time interval between the initiation of radial artery puncture and the completion of coronary angiography, until the beginning of the possible PCI
Immediately post-procedurally
Required time for coronary angiography completion, after sheath insertion
Time Frame: Immediately post-procedurally
Required time for coronary angiography completion, after sheath insertion
Immediately post-procedurally
Required time percutaneous coronary intervention completion
Time Frame: Immediately post-procedurally
Required time percutaneous coronary intervention completion
Immediately post-procedurally
Total fluoroscopy time
Time Frame: Immediately post-procedurally
Total fluoroscopy time
Immediately post-procedurally
Total Dose Area Product (DAP)
Time Frame: Immediately post-procedurally
Total Dose Area Product (DAP)
Immediately post-procedurally
Air Kerma
Time Frame: Immediately post-procedurally
Air Kerma
Immediately post-procedurally
Hemostasis time
Time Frame: 3 hours
Time required for achieving hemostasis
3 hours
Vascular complications
Time Frame: 24 hours
Vascular complications
24 hours
Hematomas classification (modified EASY classification)
Time Frame: 24 hours
Hematomas classification using modified EASY which is compatible with dTRA
24 hours
30-days Clinical follow-up (on site or via telephone call)
Time Frame: 30 days
30-days Clinical follow-up (on site or via telephone call)
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adel Aminian, MD, PhD, Centre Hospitalier Universitaire de Charleroi
  • Principal Investigator: Juan Inglesias, MD, PhD, Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
  • Principal Investigator: Grigorios Tsigkas, MD, PhD, University Hospital of Patras

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2024

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

October 10, 2022

First Submitted That Met QC Criteria

October 28, 2022

First Posted (Actual)

November 4, 2022

Study Record Updates

Last Update Posted (Actual)

May 29, 2024

Last Update Submitted That Met QC Criteria

May 25, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Coronary angiography +/- percutaneous coronary intervention

Subscribe